July 6, 2024
Patent Foramen Ovale (PFO) Closure Devices

Patent Foramen Ovale (PFO) Closure Devices: A Promising New Therapy Option In The Industry

What is a Patent Foramen Ovale (PFO) Closure Devices?

A patent foramen ovale (PFO) is a small, flap-like opening between the right and left upper chambers of the heart. In a healthy fetal heart, the foramen ovale allows blood to bypass the lungs while bypass is still occurring through the placenta. After birth, the foramen ovale usually closes on its own within the first year of life. However, in about 25% of adults, the opening fails to close completely, resulting in a PFO. While most people with a PFO do not experience health issues, research has linked PFO to certain medical conditions in some cases.

Patent Foramen Ovale (PFO) Closure Devices and Risk of Stroke

One medical condition associated with PFO is cryptogenic stroke, or stroke with no known cause. Several large-scale studies have found that people with a PFO are more likely to suffer a cryptogenic stroke than those without the heart defect. One proposed mechanism involves small blood clots that travel from veins to the arteries. In people with a Patent Foramen Ovale (PFO) Closure Devices , the clots could potentially pass from the right to left atrium of the heart and lodge in brain blood vessels, causing a stroke. Estimates suggest PFO may be responsible for up to 15-30% of cryptogenic strokes in young and middle-aged adults. While medications may help prevent recurrence in some cases, closure of the PFO is a more definitive treatment option.

Types of PFO Closure Devices

Recognizing the potential link between PFO and stroke risk, researchers developed minimally invasive devices specifically designed for PFO closure. Several FDA-approved devices are now available. The three main types currently used include:

– Amplatzer PFO Occluder: Made of self-expanding nitinol mesh framed by retention discs, this popular device blocks passage of clots through the septum.

– Helex Septal Occluder: A self-expanding plug covered in woven polyester designed to seal the defect from either side.

– CardioSEAL Septal Occluder: Similar to the Helex device, it features a nitinol frame sandwiched between two polyester discs meant to seal the PFO from within and without.

The goal of each device is similar – to promote fast, stable tissue ingrowth over the PFO, permanently sealing the opening. Accurate placement and sizing are critical factors in achieving optimal long-term results.

How is PFO Closure Performed?

Closure of a Patent Foramen Ovale (PFO) Closure Devices is usually an outpatient procedure performed in a hospital catheterization lab under local anesthesia with sedation. Physicians insert thin catheter tubes through a vein in the groin or neck while monitoring with ultrasound or fluoroscopy. Using the catheters, they thread the compressed closure device through the circulation toward the heart. Under imaging guidance, the device is then gently pushed through the PFO into proper position across the septum. Deployment, sizing checks, and imaging ensure the device is secure before removing catheters. Most patients go home the same day and resume normal activity within a week.

Effectiveness of PFO Closure

Numerous randomized controlled trials and long-term follow up studies demonstrate the effectiveness of PFO closure for reducing stroke risk in select patient groups. Here are some key findings:

– RESPECT trial: Among 980 patients followed for 2.6 years post-closure, the device group saw a significant 81% relative risk reduction in recurrent stroke or transient ischemic attack (TIA) compared to medical therapy alone.

– CLOSURE I trial: Over 5 years of follow up, PFO closure was associated with a statistically significant reduction in recurrent stroke or death compared to medical management.

– PC Trial: For patients aged 15-60 who had a cryptogenic stroke or TIA in the prior 6 months and were found to have a PFO, closure significantly reduced recurrent events over 5 years versus antiplatelet drugs.

– Long-term Registry data: Multi-year outcomes demonstrate closure devices to be safe and effective, with very low rates of complications or device failure. Residual shunting post-procedure is uncommon.

While not all studies are unanimously positive, the aggregate evidence indicates PFO closure offers substantial benefits for reducing future neurological events in select, high-risk patients. Outcomes appear to improve further when combined with antiplatelet therapy post-procedure.

Safety of the Procedure

When performed by experienced operators, PFO closure using FDA-approved devices has an excellent short and long-term safety profile. Potential risks of the procedure itself include:

– Groin/neck vascular injury at catheter entry site (rare, <1%)

– Device embolization requiring retrieval (very rare <0.5%)

– Pericardial effusion or cardiac tamponade from perforation (rare <0.5%)

However, rates of major complications are quite low, especially in the hands of high-volume centers. When balancing against risks of recurrent stroke, PFO closure appears to offer an advantageous risk-benefit ratio for many patients meeting diagnostic criteria. With continued technological advancements and growing experience, safety outcomes continue improving over time.

Patent foramen ovale defects, while common, have emerged as an important potential cause of otherwise unexplained strokes in younger individuals. Several years of clinical evidence now validate PFO closure with various FDA-approved devices as an effective treatment strategy in select patient groups. When performed by experienced operators, it safely accomplishes the goal of definitively closing the opening and reducing future neurological event risk well beyond just medication therapy alone. As knowledge of this association expands, PFO closure stands to play a growing therapeutic role for many stroke survivors.

*Note:
1. Source: Coherent Market Insights, Public Source, Desk Research
2. We have leveraged AI tools to mine information and compile it
About Author - Ravina Pandya

Ravina Pandya,a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals.  LinkedIn Profile

About Author - Ravina Pandya

Ravina Pandya, a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals.  LinkedIn Profile

View all posts by About Author - Ravina Pandya →